Citi analyst Jason Cassorla raised the firm’s price target on Tenet Healthcare to $90 from $83 and keeps a Buy rating on the shares. The company “continues the year moving in stride,” with momentum carrying through to its updated 2023 outlook that bakes in more than the Q2 beat, the analyst tells investors in a research note. The firm says Tenet’s momentum remains.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on THC: